Patents by Inventor Jeesoo Son

Jeesoo Son has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treatment of type K99 infections
    Patent number: 9211309
    Abstract: The present invention relates to a composition comprising EK99P-1, a bacteriophage isolated from nature and capable of infecting E. coli type K99 so as to kill the same, as an active ingredient, and a method for preventing and treating E. coli type K99 infections using the said composition. According to the present invention, the bacteriophage EK99P-1, an active ingredient of the composition, has a killing activity against E. coli type K99 and has the genome represented by SEQ. ID. NO: 1.
    Type: Grant
    Filed: June 26, 2014
    Date of Patent: December 15, 2015
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seongjun Yoon, Sooyoun Jun, Hyoungrok Paik, Jeesoo Son, Sanghyeon Kang
  • Method for prevention and treatment of Escherichia coli type K99 infections
    Publication number: 20150004141
    Abstract: The present invention relates to a composition comprising EK99P-1, a bacteriophage isolated from nature and capable of infecting E. coli type K99 so as to kill the same, as an active ingredient, and a method for preventing and treating E. coli type K99 infections using the said composition. According to the present invention, the bacteriophage EK99P-1, an active ingredient of the composition, has a killing activity against E. coli type K99 and has the genome represented by SEQ. ID. NO: 1.
    Type: Application
    Filed: June 26, 2014
    Publication date: January 1, 2015
    Inventors: Seongjun YOON, Sooyoun JUN, Hyoungrok PAIK, Jeesoo SON, Sanghyeon KANG
  • Bacteriophage or lytic protein derived from the bacteriophage which effective for the treatment of biofilm
    Patent number: 8377431
    Abstract: The present invention relates to compositions for removing a biofilm formed by Staphylococcus aureus, comprising a bacteriophage, such as Myoviridae family T4-like phage genus bacteriophage (Accession No: KCTC 11153BP, SAP-1) or Podoviridae family ?29-like virus genus bacteriophage (Accession No: KCTC11154BP, SAP-2), and lytic protein derived therefrom, that destroys the biofilm. Also disclosed are pharmaceutical compositions for the treatment of diseases caused by Staphylococcus aureus capable of forming biofilm.
    Type: Grant
    Filed: September 12, 2008
    Date of Patent: February 19, 2013
    Assignee: iNtRON Biotechnology, Inc.
    Inventors: Seongjun Yoon, Yunjaie Choi, Se Yung Lee, Jeesoo Son, Sooyoun Jun, Sanghyeon Kang
  • Antimicrobial protein derived from Podoviridae bacteriophage specific to
    Patent number: 8377866
    Abstract: The present invention relates to a novel antimicrobial protein derived from bacteriophage having killing activity specific to Staphylococcus aureus, more precisely an antimicrobial protein originated from Podoviridae bacteriophage having killing activity specific to Staphylococcus aureus which is the causing agent of infectious disease in human and animals, a pharmaceutical composition for the prevention and treatment of infectious disease caused by Staphylococcus aureus, an antibiotic and a disinfectant containing the bacteriophage-originated antimicrobial protein as an active ingredient.
    Type: Grant
    Filed: February 12, 2009
    Date of Patent: February 19, 2013
    Assignee: Intron Biotechnology, Inc.
    Inventors: Seongjun Yoon, Yunjaie Choi, Seyung Lee, Jeesoo Son, Sooyoun Jun, Sanghyeon Kang
  • Composition for the treatment of ballast water containing bacteriophage as an effective component and biological method with the same for removing bacteria present in ballast water
    Patent number: 8329165
    Abstract: The present invention relates to a composition for the treatment of ballast water containing bacteriophage capable of killing specific target bacteria as an active ingredient in order to eliminate or reduce bacteria including pathogenic bacteria present in ballast water, and a biological treatment method of ballast water.
    Type: Grant
    Filed: September 5, 2008
    Date of Patent: December 11, 2012
    Assignee: Intron Biotechnology, Inc.
    Inventors: Seongjun Yoon, Sooyoun Jun, Sanghyeon Kang, Yunjaie Choi, Jeesoo Son
  • Antimicrobial protein specific to
    Patent number: 8232370
    Abstract: The present invention relates to a novel bacteriophage-originated protein having antimicrobial activity, more precisely an antimicrobial protein originated from lytic bacteriophage having killing activity specific to Staphylococcus aureus which is the causing agent of infectious diseases in human and animals, a pharmaceutical composition for the prevention and treatment of the disease caused by Staphylococcus aureus, an antibiotic and a disinfectant containing the bacteriophage-originated antimicrobial protein as an active ingredient.
    Type: Grant
    Filed: July 27, 2007
    Date of Patent: July 31, 2012
    Assignee: Intron Biotechnology, Inc.
    Inventors: Seongjun Yoon, Sanghyeon Kang, Seabong Kyoung, Yunjaie Choi, Jeesoo Son
  • Bacteriophage having killing activity specific to
    Patent number: 8071352
    Abstract: The present invention relates to a novel bacteriophage, more precisely a novel bacteriophage having killing activity specific to Staphylococcus aureus which is the causing agent of infectious diseases in human and animals, a pharmaceutical composition for the prevention and treatment of the disease caused by Staphylococcus aureus, an antibiotic and a disinfectant containing the bacteriophage as an active ingredient.
    Type: Grant
    Filed: June 20, 2007
    Date of Patent: December 6, 2011
    Assignee: Intron Biotechnology, Inc.
    Inventors: Seongjun Yoon, Sanghyeon Kang, Seabong Kyoung, Yunjaie Choi, Jeesoo Son
  • Lysin protein having broad antibacterial activity specific to bacteria
    Patent number: 8066990
    Abstract: The present invention relates to a lysin protein originated from bacteriophage, more precisely a lysin protein comprising the amino acid sequence represented by SEQ. ID. NO: 2 which has no harm to human and animals comprising eukaryotic cells owing to its specificity to bacteria and has broad antibacterial activity, and a pharmaceutical composition for the prevention and treatment of infectious disease caused by bacteria comprising the said lysin protein as an active ingredient.
    Type: Grant
    Filed: April 14, 2009
    Date of Patent: November 29, 2011
    Assignee: Intron Biotechnology, Inc.
    Inventors: Seongjun Yoon, Yunjaie Choi, Jeesoo Son, Sooyoun Jun, Hyoungrok Paik, Sanghyeon Kang
  • bacteriophage having killing activity specific to
    Patent number: 8043613
    Abstract: The present invention relates to a novel bacteriophage, more precisely a Podoviridae bacteriophage having killing activity specific to Staphylococcus aureus which is the causing agent of infectious disease in human and animals, a pharmaceutical composition for the prevention and treatment of the disease caused by Staphylococcus aureus, an antibiotic and a disinfectant containing the bacteriophage as an active ingredient.
    Type: Grant
    Filed: February 12, 2009
    Date of Patent: October 25, 2011
    Assignee: iNtRON Biotechnology, Inc.
    Inventors: Seongjun Yoon, Yunjaie Choi, Seyung Lee, Jeesoo Son, Sooyoun Jun, Sanghyeon Kang
  • Bacteriophage Having Killing Activity Specific to Staphylococcus Aureus
    Publication number: 20100267117
    Abstract: The present invention relates to a novel bacteriophage, more precisely a novel bacteriophage having killing activity specific to Staphylococcus aureus which is the causing agent of infectious diseases in human and animals, a pharmaceutical composition for the prevention and treatment of the disease caused by Staphylococcus aureus, an antibiotic and a disinfectant containing the bacteriophage as an active ingredient.
    Type: Application
    Filed: June 20, 2007
    Publication date: October 21, 2010
    Applicant: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seongjun Yoon, Sanghyeon Kang, Seobong Kyoung, Yunjaie Choi, Jeesoo Son
  • Bacteriophage or lytic protein derived from the bacteriophage which effective for the treatment of staphylococcus aureus biofilm
    Publication number: 20100254950
    Abstract: The present invention relates to compositions for removing a biofilm formed by Staphylococcus aureus, comprising a bacteriophage, such as Myoviridae family T4-like phage genus bacteriophage (Accession No: KCTC 11153BP, SAP-I) or Podoviridae family ?29-like virus genus bacteriophage (Accession No: KCTC11154BP, SAP-2), and lytic protein derived therefrom, that destroys the biofilm. Also disclosed are pharmaceutical compositions for the treatment of diseases caused by Staphylococcus aureus capable of forming biofilm.
    Type: Application
    Filed: September 12, 2008
    Publication date: October 7, 2010
    Inventors: Seongjun Yoon, Yunjaie Choi, Se Yung Lee, Jeesoo Son, Sooyoun Jun, Sanghyeon Kang
  • Antimicrobial protein derived from podoviriedae bacteriophage specific to staphylococcus aureus
    Publication number: 20100203180
    Abstract: The present invention relates to a novel antimicrobial protein derived from bacteriophage having killing activity specific to Staphylococcus aureus, more precisely an antimicrobial protein originated from Podoviridae bacteriophage having killing activity specific to Staphylococcus aureus which is the causing agent of infectious disease in human and animals, a pharmaceutical composition for the prevention and treatment of infectious disease caused by Staphylococcus aureus, an antibiotic and a disinfectant containing the bacteriophage-originated antimicrobial protein as an active ingredient.
    Type: Application
    Filed: February 12, 2009
    Publication date: August 12, 2010
    Applicant: iNtRon Biotechnology, Inc.
    Inventors: Seongjun Yoon, Yunjaie Choi, Seyung Lee, Jeesoo Son, Sooyoun Jun, Sanghyeon Kang
  • Podoviriedae bacteriophage having killing activity specific to staphylococcus aureus
    Publication number: 20100203019
    Abstract: The present invention relates to a novel bacteriophage, more precisely a Podoviridae bacteriophage having killing activity specific to Staphylococcus aureus which is the causing agent of infectious disease in human and animals, a pharmaceutical composition for the prevention and treatment of the disease caused by Staphylococcus aureus, an antibiotic and a disinfectant containing the bacteriophage as an active ingredient.
    Type: Application
    Filed: February 12, 2009
    Publication date: August 12, 2010
    Applicant: iNtRON Biotechnology, Inc.
    Inventors: Seongjun Yoon, Yunjaie Choi, Seyung Lee, Jeesoo Son, Sooyoun Jun, Sanghyeon Kang
  • NOVEL LYSIN PROTEIN HAVING BROAD ANTIBACTERIAL ACTIVITY SPECIFIC TO BACTERIA
    Publication number: 20100172918
    Abstract: The present invention relates to a lysin protein originated from bacteriophage, more precisely a lysin protein comprising the amino acid sequence represented by SEQ. ID. NO: 2 which has no harm to human and animals comprising eukaryotic cells owing to its specificity to bacteria and has broad antibacterial activity, and a pharmaceutical composition for the prevention and treatment of infectious disease caused by bacteria comprising the said lysin protein as an active ingredient.
    Type: Application
    Filed: April 14, 2009
    Publication date: July 8, 2010
    Applicant: iNtRON Biotechnology, Inc.
    Inventors: SEONGJUN YOON, YUNJAIE CHOI, JEESOO SON, SOOYOUN JUN, HYOUNGROK PAIK, SANGHYEON KANG
  • Antimicrobial Protein Specific to Staphylococcus Aureus
    Publication number: 20100144619
    Abstract: The present invention relates to a novel bacteriophage-originated protein having antimicrobial activity, more precisely an antimicrobial protein originated from lytic bacteriophage having killing activity specific to Staphylococcus aureus which is the causing agent of infectious diseases in human and animals, a pharmaceutical composition for the prevention and treatment of the disease caused by Staphylococcus aureus, an antibiotic and a disinfectant containing the bacteriophage-originated antimicrobial protein as an active ingredient.
    Type: Application
    Filed: July 27, 2007
    Publication date: June 10, 2010
    Applicant: iNTRON Biotechnology, Inc.
    Inventors: Seongjun Yoon, Sanghyeon Kang, Seobong Hyoung, Yunjaie Choi, Jeesoo Son
  • Composition for the treatment of ballast water containing bacteriophage as an effective component and biological method with the same for removing bacteria present in ballast water
    Publication number: 20090304638
    Abstract: The present invention relates to a composition for the treatment of ballast water containing bacteriophage capable of killing specific target bacteria as an active ingredient in order to eliminate or reduce bacteria including pathogenic bacteria present in ballast water, and a biological treatment method of ballast water.
    Type: Application
    Filed: September 5, 2008
    Publication date: December 10, 2009
    Applicant: iNtRON Biotechnology, Inc.
    Inventors: Seongjun Yoon, Sooyoun Jun, Sanghyeon Kang, Yunjaie Choi, Jeesoo Son